Infectious Disorders - Drug Targets

Formerly Current Drug Targets - Infectious Disorders

Editor-in-Chief

Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
(France)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Abstract Ahead of Print

COVID-19 and Infectious Disease Speciality – A necessity of Time in India.

Volume:21
Gopal K Bohra, Deepak Kumar* and Mahendra K Garg

The recovery of an elderly woman with asthma and diabetes from COVID-19 infection: a case report

Volume:21
Abas Ghaysouri, Maryam Safari, Elham Mohammadyari, Firooz Balavandi, Ali Nazari, Jalil Feizi, Mohamad Karimian, Elham Bastani, Ebrahim Salimi and Hamed Tavan*

Natural Derived Nasal Spray; a Proposed Approach for COVID-19 Disease Control

Volume:21
Zahra Hoseini-Tavassol, Hanieh-Sadat Ejtahed, Ahmad-Reza Soroush, Zahra Sajjadpour, Shirin Hasani-Ranjbar* and Bagher Larijani

COVID-19: Potential Repurposing Drugs

Volume:21
Wattana Leowattana*

A mini review on the pathogenesis, diagnosis and treatment options for COVID-19

Volume:21
Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, Gordon A Ferns, Majid Khazaei, Soodabeh Shahidsales and Amir Avan*

Prevalence of Genes Encoding Aminoglycoside-Modifying Enzymes and armA among Acinetobacter baumannii Clinical Isolates in Alexandria, Egypt

Volume:21
Amel ELsheredy *, Zainab Yousif , Ebtesam Elghazzawi , Ahmed Elmenshawy and Abeer Ghazal

Serratia no longer an opportunistic uncommon pathogen – case series & review of literature

Volume:21
Varsha Gupta, Shiwani Sharma*, Kritika Pal, Poonam Goyal, Deepak Agarwal and Jagdish Chander

Increased level of interleukin-8 in female genital tract after HP eradication lines

Volume:21
Viacheslav Kravtsov*, Tatiana Surovtceva, Maria Taame, Yuriy Grukhin and Natalia Kalinina

COVID-19 and Neurology – An Emerging Association

Volume:21
Amit Gupta, Prakrati Yadav* and Deepak Kumar

Hepatic involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran

Volume:21
Ahmad Hormati, Mohammad Reza Ghadir, Mohammad Saeidi, Reza Aminnejad, Mahboubeh Afifian and Sajjad Ahmadpour*